These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20228397)

  • 1. The PGC1alpha-PPARdelta-HO-1 system: supporting evidence from studies in Bartter's/Gitelman's syndromes.
    Calò LA; Davis PA
    Cardiovasc Res; 2010 Jun; 86(3):535. PubMed ID: 20228397
    [No Abstract]   [Full Text] [Related]  

  • 2. Number and function of circulating endothelial progenitor cells and calcitonin gene-related peptide in hypertension: support from and opportunities in Bartter's and Gitelman's syndromes patients.
    Calò LA; Davis PA
    J Hypertens; 2010 Oct; 28(10):2169-70; author reply 2171. PubMed ID: 20844372
    [No Abstract]   [Full Text] [Related]  

  • 3. Does Bartter's syndrome/Gitelman's syndrome provide a clinical model for investigating the association between calcitonin gene-related peptide and angiotensin II-mediated senescence of endothelial progenitor cells?
    Tura O; Mills NL; Hadoke PW
    J Hypertens; 2010 Oct; 28(10):2170-1; author reply 2171. PubMed ID: 20844373
    [No Abstract]   [Full Text] [Related]  

  • 4. SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: implications for hypertension.
    Davis PA; Pagnin E; Dal Maso L; Caielli P; Maiolino G; Fusaro M; Paolo Rossi G; Calò LA
    Hypertens Res; 2013 Oct; 36(10):873-8. PubMed ID: 23698802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking inflammation and hypertension in humans: studies in Bartter's/Gitelman's syndrome patients.
    Caló LA; Davis PA; Pagnin E; Schiavo S; Semplicini A; Pessina AC
    J Hum Hypertens; 2008 Mar; 22(3):223-5. PubMed ID: 18046435
    [No Abstract]   [Full Text] [Related]  

  • 6. PPARdelta and PGC1alpha act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress.
    Ali F; Ali NS; Bauer A; Boyle JJ; Hamdulay SS; Haskard DO; Randi AM; Mason JC
    Cardiovasc Res; 2010 Mar; 85(4):701-10. PubMed ID: 19903700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathophysiology of Bartter's and Gitelman's syndromes.
    Koulouridis E; Koulouridis I
    World J Pediatr; 2015 May; 11(2):113-25. PubMed ID: 25754753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxes in magnesium transport in type 1 Bartter's syndrome and Gitelman's syndrome: a modeling analysis.
    Dutta P; Layton AT
    Am J Physiol Renal Physiol; 2024 Sep; 327(3):F386-F396. PubMed ID: 38991009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways.
    Calò LA; Puato M; Schiavo S; Zanardo M; Tirrito C; Pagnin E; Balbi G; Davis PA; Palatini P; Pauletto P
    Nephrol Dial Transplant; 2008 Sep; 23(9):2804-9. PubMed ID: 18344243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes.
    Calò LA; Maiolino G
    J Endocrinol Invest; 2015 Jul; 38(7):711-6. PubMed ID: 25740064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The search for a link between inflammation and hypertension--contribution from Bartter's/Gitelman's syndromes.
    Pagnin E; Davis PA; Semplicini A; Calò LA
    Nephrol Dial Transplant; 2006 Aug; 21(8):2340-2. PubMed ID: 16611677
    [No Abstract]   [Full Text] [Related]  

  • 12. HO-1 attenuates hypertension-induced inflammation/oxidative stress: support from Bartter's/Gitelman's patients.
    Calò LA; Fusaro M; Davis PA
    Am J Hypertens; 2010 Sep; 23(9):936; author reply 937. PubMed ID: 20733571
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes.
    Watt MJ; Southgate RJ; Holmes AG; Febbraio MA
    J Mol Endocrinol; 2004 Oct; 33(2):533-44. PubMed ID: 15525607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the Clinical Presentations (Phenotypes) of Gitelman's and Bartter's Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their "pH" Enotype?
    Calò LA; Davis PA
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miscellaneous non-inflammatory musculoskeletal conditions. Bartter's and Gitelman's diseases.
    Favero M; Calò LA; Schiavon F; Punzi L
    Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):637-48. PubMed ID: 22142744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypokalemic nephropathy in an adult patient with partial empty sella: a classic Bartter's syndrome, a Gitelman's syndrome or both?
    Addolorato G; Ancarani F; Leggio L; Abenavoli L; de Lorenzi G; Montalto M; Staffolani E; Zannoni GF; Costanzi S; Gasbarrini G
    Panminerva Med; 2006 Jun; 48(2):137-42. PubMed ID: 16953151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary albumin excretion, endothelial dysfunction and cardiovascular risk: study in Bartter's/Gitelman's syndromes and relevance for hypertension.
    Calò LA; Davis PA; Palatini P; Semplicini A; Pessina AC
    J Hum Hypertens; 2007 Nov; 21(11):904-6. PubMed ID: 17495949
    [No Abstract]   [Full Text] [Related]  

  • 18. Bartter/Gitelman syndromes as a model to study systemic oxidative stress in humans.
    Maiolino G; Azzolini M; Rossi GP; Davis PA; Calò LA
    Free Radic Biol Med; 2015 Nov; 88(Pt A):51-8. PubMed ID: 25770663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE2/Angiotensin 1-7 protective anti-inflammatory and antioxidant role in hyperoxic lung injury: support from studies in Bartter's and Gitelman's syndromes.
    Calò LA; Rigato M; Bertoldi G
    QJM; 2020 Jun; 113(6):440-441. PubMed ID: 31851364
    [No Abstract]   [Full Text] [Related]  

  • 20. Gitelman's and Bartter's Syndromes: From Genetics to the Molecular Basis of Hypertension and More.
    Ravarotto V; Bertoldi G; Stefanelli LF; Nalesso F; Calò LA
    Kidney Blood Press Res; 2022; 47(9):556-564. PubMed ID: 35858584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.